---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-005780"
form_type: "8-K"
ticker: "MBOT"
cik: "0000883975"
company_name: "Microbot Medical Inc."
filed_at: "2025-04-23T23:59:59+00:00"
generated_at: "2026-05-23T08:45:14.516057+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Microbot Medical adds VP Marketing, Director HR, raises ~$2.3M from option exercises ahead of FDA decision

## Summary
- Issued 1,533,336 common shares upon exercise of Series F and Series E preferred investment options at $1.50/share, generating ~$2.3M gross proceeds.
- Appointed Allison Rosefort as VP of Marketing; she brings 15+ years MedTech marketing experience, most recently at Topcon Healthcare.
- Appointed Lisa Dobbins as Director, Human Resources; she previously was HR Business Partner at Integra LifeSciences.
- Company preparing for U.S. commercial launch of LIBERTY Endovascular Robotic System ahead of expected FDA decision in Q2 2025.

## SEC filing metadata
- accession: 0001641172-25-005780
- form_type: 8-K
- ticker: MBOT
- cik: 0000883975
- company_name: Microbot Medical Inc.
- filed_at: 2025-04-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883975/000164117225005780/0001641172-25-005780-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883975/000164117225005780/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-005780
- JSON: https://secwatch.observer/filing/0001641172-25-005780.json
- Plain text: https://secwatch.observer/filing/0001641172-25-005780.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.